RamRajya News

Medistep Healthcare IPO Sees 5x Demand on Day 1

RR Team

Medistep Healthcare IPO Soars on Day 1

Medistep Healthcare’s SME IPO kicked off on a high note on August 8, 2025. The response from investors was overwhelming, with the issue being nearly 5 times oversubscribed within just a few hours.

This surge reflects the strong confidence in the company’s future and the sector’s robust outlook. Here’s everything you need to know about the Medistep Healthcare IPO — from subscription status to GMP, issue price, lot size, and listing date.

IPO Booked Nearly 5x on Day 1

According to stock exchange data available till 1:20 PM on August 8, the IPO was subscribed 4.62 times.

Retail investors led the charge, with their portion getting booked 7.84 times. The non-institutional investor (NII) category was also strong, subscribed 1.40 times.

Out of the 35.55 lakh shares offered, the IPO received bids for a whopping 1.64 crore shares.

Grey Market Premium Hints at 35% Listing Gains

The Medistep Healthcare IPO GMP (Grey Market Premium) stood at ₹15 on the first day of issue.

Though slightly down from ₹17 earlier in the week, it still reflects a strong market sentiment. At this rate, the stock is expected to list around ₹58 per share against the issue price of ₹43 — indicating a 34.88% premium.

IPO Details: Price, Lot Size & Issue Structure

Medistep plans to use the raised capital for:

Important Dates to Watch

Fast Track Finsec Pvt Ltd is the lead manager for the issue, while Cameo Corporate Services is acting as the registrar.

Company Profile: Medistep Healthcare

Medistep Healthcare operates in the pharmaceutical and healthcare products sector.

It trades and manufactures products in the following categories:

With a focus on quality and R&D-driven product development, Medistep is targeting rapid expansion in India’s booming healthcare and wellness segment.

What Should Investors Consider?

Analysts are bullish due to:

However, investors should remember the high entry barrier due to the large lot size (₹2.58 lakh). Also, SME IPOs carry higher risks compared to mainboard issues.

Investor Sentiment Remains Positive

In a market where investors are chasing growth in healthcare and small-cap segments, Medistep Healthcare’s IPO looks promising. The near 5x oversubscription on Day 1 is a strong indicator of investor trust.

With its diversified product base and aggressive expansion strategy, the company appears well-positioned to deliver value post-listing — especially if GMP trends hold.

Final Thoughts

The Medistep Healthcare IPO has made a strong debut in the subscription phase. If the GMP sustains and demand continues, a premium listing is very likely.

Still, investors should weigh risks carefully and consult financial advisors before subscribing. After all, every IPO is a window of opportunity, but timing and research matter most.

Suggested Images

1. Featured Image

2. Inline Image

SEO Key Phrases / Hashtags

#MedistepIPOPrice

 

—

Would you like this as a downloadable HTML file, or would you like help embedding it into your website (e.g., WordPress, Blogger, or a custom CMS)?

Exit mobile version